Showing results (21-30 of 178) with videos related to
Sort By:
Pageof 18
Clinical and Experimental Pharmacology & Physiology|August 10, 2004
Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophyGordon S LynchAmerican Journal of Physiology. Heart and Circulatory Physiology|January 1, 2016
The pathogenesis and treatment of cardiac atrophy in cancer cachexiaKate T MurphyFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 2014
Elevated expression of activins promotes muscle wasting and cachexiaJustin L Chen, Kelly L Walton, Catherine E Winbanks, et al.Regenerative Medicine|October 8, 2025
Translational progress in the development of pharmacotherapies for Duchenne muscular dystrophyKristy Swiderski, Gordon S LynchMeat Science|June 27, 2018
Dietary meat and protection against sarcopeniaGordon S Lynch, René KoopmanThe American Journal of Pathology|October 18, 2016
BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal MuscleTahnee L Kennedy, Kristy Swiderski, Kate T Murphy, et al.American Journal of Physiology. Cell Physiology|May 2, 2003
Depolarization-induced contraction and SR function in mechanically skinned muscle fibers from dystrophic mdx miceDavid R Plant, Gordon S LynchExpert Opinion on Emerging Drugs|February 18, 2011
Emerging drugs for treating skeletal muscle injury and promoting muscle repairStefan M Gehrig, Gordon S LynchExpert Opinion on Pharmacotherapy|May 24, 2019
Current pharmacotherapies for sarcopeniaJustin P Hardee, Gordon S LynchPharmacology & Therapeutics|October 7, 2008
The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wastingJames G Ryall, Gordon S LynchPageof 18